March 16, 2017 – InSphero Launches 3D InSight™ Monkey Liver Microtissues at Annual Society of Toxicology Meeting
InSphero Launches 3D InSight™ Monkey Liver Microtissues at Annual Society of Toxicology Meeting 3D liver microtissues comprised of cynomolgus hepatocytes provide physiologically relevant in vitro model for investigating species-specific liver […]
Read MoreFebruary 02, 2017 – InSphero to Introduce GravityTRAP™ 384 Microtissue Platform at SLAS2017
InSphero to Introduce GravityTRAP™ 384 Microtissue Platform at SLAS2017 Global leader in 3D cell culture technology to deliver standardized 3D models in new high-throughput, high-content-imaging-optimized format. PDF Version Schlieren, Switzerland […]
Read MoreNovember 03, 2016 – InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System
InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System Dr. Olivier Frey honored by IQ Consortium and AAALAC International for work on microphysiological system to reduce animal-based […]
Read MoreOctober 20, 2016 – 3D Cell Culture Experts Assemble for Inaugural New Frontiers in 3D Conference
3D Cell Culture Experts Assemble for Inaugural New Frontiers in 3D Conference Event draws over 100 leading government, industry, and academic leaders to further translational applications of 3D tissue models. […]
Read MoreSeptember 21, 2016 – InSphero, US Congressional Leaders Discuss Technologies to Reduce Animal Research
InSphero, US Congressional Leaders Discuss Technologies to Reduce Animal Research US legislators and InSphero experts discuss benefits of human-derived 3D microtissues for more efficient drug development and less animal testing. […]
Read MoreSeptember 07, 2016 – InSphero Launches 3D Mitochondrial Toxicity Testing Service
InSphero Launches 3D Mitochondrial Toxicity Testing Service New contract screening offering combines advanced 3D liver microtissue models and Agilent XFe96 Analyzer to identify mitochondrial liabilities for drug safety testing market. […]
Read MoreJuly 13, 2016 – Registration Open for New Frontiers in 3D Cell Culture-based Screening Technologies Conference
Registration Open for New Frontiers in 3D Cell Culture-based Screening Technologies Conference Schlieren, Switzerland, July 13, 2016 – Inaugural meeting, organized by InSphero AG, NCATS, CAAT, and Promega Corp., to […]
Read MoreJuly 11, 2016 – InvitroCue Commences Pancreatic Toxicity Assay Development
InvitroCue Commences Pancreatic Toxicity Assay Development 11 July 2016 – InvitroCue (ASX:IVQ), a leader in advanced bio-analytics, has progressed its technology in modelling multi-organ toxicity by developing a novel assay […]
Read MoreJune 16, 2016 – Nature Scientific Reports Article Touts Versatility, Promise of 3D Human Liver Microtissues for Drug Development
Nature Scientific Reports Article Touts Versatility, Promise of 3D Human Liver Microtissues for Drug Development Schlieren, Switzerland, June 16, 2016 – Liver spheroids display longer culture lifetime, liver-like functionality, and […]
Read MoreMarch 16, 2016 – InSphero Launches Multi-donor Human Liver Microtissues for Prediction of Drug-induced Liver Injury
InSphero Launches Multi-donor Human Liver Microtissues for Prediction of Drug-induced Liver Injury Schlieren, Switzerland, March 16, 2016 – 3D human liver microtissues comprised of pooled hepatocytes from multiple donors offers […]
Read More